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Background: Formaldehyde can induce misfolding and aggregation of Tau protein and β amyloid protein, which
are characteristic pathological features of Alzheimer’s disease (AD). An increase in endogenous formaldehyde
concentration in the brain is closely related to dementia in aging people. Therefore, the discovery of effective drugs
to counteract the adverse impact of formaldehyde on neuronal cells is beneficial for the development of
appropriate treatments for age-associated cognitive decline.
Methods: In this study, we assessed the neuroprotective properties of TongLuoJiuNao (TLJN), a traditional Chinese
medicine preparation, against formaldehyde stress in human neuroblastoma cells (SH-SY5Y cell line). The effect of
TLJN and its main ingredients (geniposide and ginsenoside Rg1) on cell viability, apoptosis, intracellular antioxidant
activity and the expression of apoptotic-related genes in the presence of formaldehyde were monitored.
Results: Cell counting studies showed that in the presence of TLJN, the viability of formaldehyde-treated SH-SY5Y cells
significantly recovered. Laser scanning confocal microscopy revealed that the morphology of formaldehyde-injured
cells was rescued by TLJN and geniposide, an effective ingredient of TLJN. Moreover, the inhibitory effect of geniposide
on formaldehyde-induced apoptosis was dose-dependent. The activity of intracellular antioxidants (superoxide
dismutase and glutathione peroxidase) increased, as did mRNA and protein levels of the antiapoptotic gene Bcl-2 after
the addition of geniposide. In contrast, the expression of the apoptotic-related gene - P53, apoptotic executer - caspase
3 and apoptotic initiator - caspase 9 were downregulated after geniposide treatment.
Conclusions: Our results indicate that geniposide can protect SH-SY5Y cells against formaldehyde stress through
modulating the expression of Bcl-2, P53, caspase 3 and caspase 9, and by increasing the activity of intracellular
superoxide dismutase and glutathione peroxidase.
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Reactive aldehydes are generated by several endogenous
and exogenous processes in biological systems. They target
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reproduction in any medium, provided the orapoptosis [1]. Reactive aldehydes are associated with the
etiology of several neurological and psychiatric disorders
including chronic alcohol abuse, vascular dementia and
Alzheimer’s disease (AD) [2-4].
Formaldehyde is one of the reactive aldehydes with
important clinical implications. He et al. summarized
that formaldehyde can influence nerve function and that
it is linked to the development of psychiatric disorders
[5]. An epidemiological study has shown that histology
technicians and workers who are chronically exposed to
formaldehyde exhibit a marked decline in cognitive ability
[6]. Formaldehyde concentrations in the hippocampus and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Sun et al. BMC Complementary and Alternative Medicine 2013, 13:152 Page 2 of 12
http://www.biomedcentral.com/1472-6882/13/152urine of AD patients are significantly higher than those of
healthy aged individuals [7]. The activity of mitochondrial
aldehyde dehydrogenases, the main metabolic enzyme of
formaldehyde, is significantly increased in the putamen of
AD patients [1]. Furthermore, formaldehyde induces the
hyperphosphorylation and aggregation of neuronal Tau pro-
tein [8] and aggregation of Tau protein in vitro and in vivo
[9-11]. These misfolded amorphous deposits are able to
induce apoptosis of human neuroblastoma cells (SH-SY5Y
cell line) and primary rat hippocampal cells [9]. Formalde-
hyde can also promote the misfolding, oligomerization, and
fibrillogenesis of β amyloid protein (Aβ) [12]. Therefore,
formaldehyde is closely related to age-associated dementia.
Recently, the discovery of effective drugs to counteract the
adverse impacts of formaldehyde on the central nervous
system and promoting the survival of neuronal cells, has
become of great interest to many neuropharmacologists.
TongLuoJiuNao (TLJN), a traditional Chinese medi-
cine (TCM), is clinically efficacious in the treatment of
ischemic cerebral stroke and dementia (Chinese SFDA:
2004 L01620). It has been reported that TLJN can protect
brain tissue against ischemia after the induction of middle
cerebral artery occlusion in rats, by reducing not only
infarct volume but also penumbra size [13], and alleviate
the damage to ischemia/reperfusion-injured neurons [14].
Moreover, TLJN can improve learning and memory ability,
promote the degradation of Aβ, and clear amyloid plaques
from the AD rat brain [15]. The main ingredients of TLJN
are geniposide and ginsenoside Rg1 [14]. Ginsenoside Rg1
has neuroprotective effects in mesencephalic dopaminergic
cells stressed with glutamate [16], while geniposide can
protect PC12 cells from hydrogen peroxide-induced cell
death via its involvement in the PI3K signaling pathway
and its ability to activate the glucagon-like peptide 1
receptor (GLP-1R) [15]. Geniposide is also able to regulate
insulin secretion through activating GLP-1R [16]. Thus,
TLJN (geniposide and ginsenoside Rg1) is likely to be an
appropriate drug for the treatment of dementia. However,
whether it has any protective effects on reactive aldehyde-
treated neuronal cells, in particular formaldehyde-stressed
neurons, remains unclear.
Direct addition of formaldehyde to the cell culture
medium is a common cell culture model used in studies
on aldehyde toxicity [15]. Here, we examined the
neuroprotective effects of TLJN and its main ingredients,




TLJN was provided by Kangyuan Pharmaceutical
Engineering Co. Ltd (Beijing, China). The concentra-
tions of geniposide (4.95 mg/mL) and ginsenoside
Rg1 (1.02 mg/mL) in TLJN were determined by highperformance liquid chromatography (HPLC; Figure 1)
[14]. The purified geniposide and ginsenoside Rg1
were from the National Institutes for Food and Drug
Control (Beijing, China). The cell counting Kit-8
(CCK-8) for measurement of cell viability was from
Dojindo Co. (Kumamoto, Japan). Hoechst33258 was from
Sigma and Alexa Fluor 488 Phalloidin was from Invitrogen
(Carlsbad, CA, USA). The primary antibody against Bcl-2
was purchased from Cell Signaling Technology (Waltham,
MA, USA) and the β-actin antibody was from Beyotime
Institute of Biotechnology (Jiangsu, China). The enhanced
chemiluminescence (ECL) substrate was from Pierce
(Boston, MA, USA) and polyvinylidene difluoride (PVDF)
membrane was purchased from Millipore (Billerica,
MA, USA). The annexin V apoptosis detection kit,
total superoxide dismutase (SOD) assay kit with
WST-1, cellular glutathione peroxidase (GSHPx) assay kit
and catalase assay kit were from the Beyotime Institute of
Biotechnology (Jiangsu, China). The Taq DNA Polymerase
and TansStartTM Green qPCR SuperMix were purchased
from Transgen Inc. (Beijing, China). The primers for
Bcl-2, P53, caspase 3, caspase 9, β-actin and 18 s RNA
were designed and synthesized by Shanghai Sangon
Biotech Co. Ltd (Shanghai, China).
Cell culture
SH-SY5Y cells were grown in Dulbecco’s modified eagle
medium (DMEM) containing 10% (v/v) fetal bovine serum
(Invitrogen) and maintained in 5% (v/v) CO2/90% (v/v)
humid air at 37°C. Cells were plated onto 96-well culture
plates at a density of 1 × 104 cells/well for cytotoxicity
assays or 60-mm culture dishes at a density of 1 × 106 cells/
well for western blotting, RT-PCR, flow cytometry, and
total SOD detection. After 24 h, the culture medium was
replaced with serum-free DMEM supplemented with
0.12 mM formaldehyde, and different concentrations of
drugs were used to treat cells as indicated in the results.
Cell viability assay
The viability of cells was evaluated using the CCK-8
kit. Briefly, 10 μL of the CCK-8 solution was added
to each well of the 96-well plate and left to incubate
for 4 h in the incubator at 37°C. According to the
manufacturer, simultaneous absorbance readings were
measured at 450 and 630 nm using a microplate
reader. The difference between the two readings was
used in the final analysis.
Cell morphology analysis
SH-SY5Y cells (plated at 3 × 105) were grown in DMEM
containing 10% (v/v) fetal bovine serum in 5% (v/v)
CO2/90% (v/v) humid air at 37°C. After 12 h of plating,
the culture medium was replaced with serum-free
DMEM in the presence of 0.12 mM formaldehyde
Figure 1 Chemical structures and HPLC analysis of TLJN. A. Geniposide (C16H24O10, molecular weight 388 Da); B. Geniposidic acid (C16H22O10,
molecular weight 374 Da); C. Ginsenoside Rg1 (C42H72O14, molecular weight 800 Da); D. HPLC analysis of TLJN.
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ginsenoside Rg1 or TLJN, which consisted of 100 μM
geniposide and 10 μM ginsenoside Rg1. At different
time intervals (6, 12, and 24 h), cells were fixed with
4% (w/v) paraformaldehyde. Hoechst33258 was applied
to label the nuclei and F-actin was labeled with
phalloidin. All images were obtained by laser scan-
ning confocal microscopy (LSCM; Olympus FV1000,
Tokyo, Japan).Analysis of apoptosis
Analysis of apoptosis was carried out by flow cytometry
using the annexin V apoptosis detection kit. Cells were
harvested, counted, and resuspended in 1 x binding
buffer at a concentration of 1 × 106 cells/mL. The cell
suspension (100 μL) was transferred to a 5 mL culture
tube and 5 μL of Annexin V-FITC was added. The
suspension was gently mixed and incubated for 10 min
at room temperature in the dark. Propidium iodide (PI)
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cytometry (FACSCalibur, BD Biosciences, San Jose, CA,
USA) within 1 h.
Western blotting
Western blotting was carried out as previously described
[17]. SH-SY5Y cell lysates were prepared and 50 μg
of protein was loaded on a 12% (w/v) sodium
dodecylsulfate-polyacrylamide gel. The separated proteins
were transferred to PVDF membrane and the membrane
was hybridized with an anti-Bcl-2 monoclonal antibody
(1:1000 dilution) or anti-β-actin monoclonal antibody
(1:5000 dilution). Horse radish peroxidase-conjugated
anti-rabbit/mouse IgG was used as the secondary antibody
(1:5000 dilution).
RT-PCR analysis
The expression of the apoptotic-related genes was
detected by RT-PCR. Total RNA was extracted from
SH-SY5Y cells using Trizol reagent (Invitrogen). The
integrity of RNA was examined by identifying intact
18 s and 28 s ribosomal RNA bands upon agarose gel
electrophoresis. The purity and quantity were estimated by
measuring the absorbance at 260/280 nm spectrophoto-
metrically. RNA was reverse-transcribed into cDNA using
M-MLV reverse transcriptase (Transgen Inc.). Quantitative
real time PCR was performed using TansStartTM Green
qPCR SuperMix (UDG) (Transgen Inc.) according to
the following reaction conditions: 50°C 2 min (UDG
Incubation), 95°C 10 min (UDG Inactivation), 40–45 cycles:
5 sec 95°C, 15 sec 55°C (according to different primers),
and 10 sec 72°C. The collected data were analyzed using
Rotor-Gene 6000 Series Software 1.7 (Qiagen, Valencia,
CA, USA). Normal RT-PCR was performed using Taq
DNA Polymerase (Transgen Inc.) and detected by gel
electrophoresis. The PCR primers were designed by
Primerpremier 5.0 software and synthesized by Shanghai
Sangon Inc. (Shanghai, China). The primers for Bcl-2 were
(TM: 55°C), forward: 5′-tgtgtggagagcgtcaacag-3′ and
reverse: 5′-cagacatgcacctacccagc-3′; for 18 s RNA
(TM: 55°C), forward: 5′-cagccacccgagattgagca-3′ and
reverse: 5′-tagtagcgacgggcggtgtg-3′; for P53 (TM: 60°C),
forward: 5′-acagctttgaggtgcgtgttt -3′ and reverse: 5′-
ccctttcttgcggagattctct-3′; for caspase 3 (TM: 53°C),
forward: 5′-gaaattgtggaattgatgcgtga-3′ and reverse:
5′-ctacaacgatcccctctgaaaaa-3′; for caspase 9 (TM: 53°C),
forward: 5′-cttcgtttctgcgaactaacagg-3′ and reverse: 5′-
gcaccactggggtaaggttt-3′; for β-actin (TM: 60°C),
forward: 5′-catgtacgttgctatccaggc-3′ and reverse: 5′-
ctccttaatgtcacgcacgat-3′.
Assay for SOD, GSHPx and catalase activity
SH-SY5Y cells were harvested and then lysed using cell
lysis solution (Beyotime Institute of Biotechnology,Jiangsu, China). Total protein concentration was quantified
using the BCA Protein Assay Kit (Thermo Fisher Scientific
Inc., Boston, MA, USA). The activity of SOD was
determined using the total SOD assay kit with WST-1.
The activities of GSHPx and catalase were determined
using the cellular glutathione peroxidase assay kit and
catalase assay kit according to the manufacturers’
instructions.Statistical analysis
Each experiment was repeated at least three times and
results were expressed as the mean ± standard deviation
(SD). Analysis of variance was carried out using SPSS
11.0 (SPSS, Chicago, IL, USA). Values of P < 0.05 were
considered statistically significant.Results
Geniposide, an active ingredient of TLJN, rescues the
viability of SH-SY5Y cells treated with formaldehyde
TLJN preparation is clinically efficacious in the treat-
ment of ischemic cerebral stroke and dementia
[14,17]. In previous studies, we identified that TLJN
has neuroprotective effects on ischemia/reperfusion-
injured neurons and brain microvascular endothelial
cells [14,18]. In this study, we investigated whether
TLJN had a neuroprotective effect on formaldehyde-
injured cells. SH-SY5Y cells (plated at 1×104) were
grown in serum-free DMEM in the presence of
0.12 mM formaldehyde supplemented with TLJN,
geniposide or ginsenoside Rg1, to monitor changes in cell
viability using CCK-8. As shown in Figure 2A, the relative
viability of cells following formaldehyde treatment
significantly decreased to 56.5% after a 24 h incubation
when compared with the control (100% viability) in the
absence of formaldehyde (P < 0.05). However, in the
presence of TLJN, cell viability was maintained at
control levels, indicating its ability to rescue SH-SY5Y
cells from formaldehyde injury.
As described previously [17], the effective components of
TLJN are geniposide and ginsenoside Rg1. First, geniposide
was employed to protect the cells in the presence of
formaldehyde. The viability of cells supplemented with
both formaldehyde and geniposide was significantly
higher than that with formaldehyde alone (P < 0.05,
Figure 2A). Treatment with different concentrations
of geniposide (2.5, 25, 100 and 250 μM) revealed that
25 μM (or higher concentrations) of geniposide
significantly elevated cell viability from 39.3% to
57.6% (P < 0.05, Figure 2B). Second, the protective
effect of ginsenoside Rg1 on cells was tested under the
same conditions. In contrast, ginsenoside Rg1 could not
significantly rescue the viability of cells following
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Figure 2 TLJN and geniposide rescue SH-SY5Y cells following
formaldehyde treatment. SH-SY5Y cells were grown (1×104) in
96-well plates overnight, and the culture medium was then replaced
with serum-free DMEM in the presence of 0.12 mM formaldehyde,
supplemented with TLJN (containing 100 μM geniposide and 10 μM
ginsenoside Rg1), 100 μM geniposide, or 10 μM ginsenoside Rg1.
Cell viability was evaluated using the cell counting kit-8 after a 24h
incubation. Cells cultured without formaldehyde or drugs were used
as a control (A). Changes in SH-SY5Y cell viability following
treatment with different concentrations of geniposide (250, 100, 25
and 2.5 μM) in the presence of formaldehyde for 24 h (B) were
detected. Data are expressed as the mean ± SD from at least three
independent experiments. *P < 0.05, **P < 0.01 vs. formaldehyde-only
treated group.
Sun et al. BMC Complementary and Alternative Medicine 2013, 13:152 Page 5 of 12
http://www.biomedcentral.com/1472-6882/13/152Geniposide rescues the morphology of SH-SY5Y cells in
the presence of formaldehyde
Changes in cell morphology were also observed by laser
scanning confocal microscopy at different time intervals
following incubation (Figure 3). As shown in Figure 3E,
SH-SY5Y cells treated with formaldehyde for 6 h
shrank considerably when compared with the control
(Figure 3A). This adverse effect of formaldehyde oncell growth was also observed at 12 and 24 h (Figure 3J
and 3O). Cell morphological changes at 6 h were not
significantly rescued in the presence of TLJN, geniposide
or ginsenoside Rg1 when compared with formaldehyde
treatment alone (Figure 3B, C, and D), suggesting that
they did not exert a significant protective effect on cell
growth at this early time point. Surprisingly, when cells
were left for 12 h, the shape of SH-SY5Y cells incubated
with formaldehyde plus TLJN appeared to be much
healthier than the formaldehyde-treated only group
(Figure 3G to 3J). A similar effect was found in cells
supplemented with geniposide (Figure 3H). However,
there was no significant difference between formaldehyde
treatment and formaldehyde plus ginsenoside Rg1
treatment (Figure 3J to 3I). These results indicate that
geniposide is the key component of TLJN that protects
cells from the adverse effects of formaldehyde.
The numbers of surviving cells were also monitored
in our study (Figure 3P). Formaldehyde treatment
significantly decreased cell number at 12 and 24 h,
revealing its neurotoxic effect (P < 0.01). TLJN and
geniposide significantly rescued the number of SH-SY5Y
cells treated with formaldehyde at both 12 and 24 h
(P < 0.01), indicating that geniposide but not ginsenoside
Rg1 is able to rescue the viability of formaldehyde-injured
SH-SY5Y cells under our experimental conditions.
The protective effect of ginsenoside Rg1 on cellular
morphology and cell number could not be detected.
We were next concerned with why geniposide can
rescue formaldehyde-treated SH-SY5Y cells. First, HPLC
was used to measure changes in the concentrations of
formaldehyde in the cell culture medium. The results
showed that the residual content of formaldehyde
decreased by 20% in the presence of 25 μM geniposide
(P < 0.05, Figure 4A). We also confirmed that at the
concentrations used in the experiments, geniposide,
ginsenoside Rg1, and TLJN showed no cytotoxicity to
SH-SY5Y cells (Figure 4B). Overall, these results suggest
that geniposide rescues formaldehyde-treated cells at least
through its capability of decreasing formaldehyde levels.
Thus, we next explored the mechanism of this protective
effect of geniposide on SH-SY5Y cells.
Protection of SH-SY5Y cells is not caused by a direct
interaction of geniposide with formaldehyde in the
culture medium
Because both geniposide and formaldehyde were
added to SH-SY5Y cells at the same time, and it was
shown that geniposide decreased cytotoxicity following
formaldehyde treatment, we could not exclude the
possibility that geniposide directly interacted with
formaldehyde and then rescued the viability of cells.
Therefore, in the following experiment we added
geniposide to the cell culture medium before cells
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Figure 3 TLJN and geniposide have a neuroprotective effect on SH-SY5Y cells exposed to formaldehyde. Conditions were set as per
Figure 2, except for the observation of nuclei (Hoechst, blue) and F-actin (Phalloidin, green). SH-SY5Y cells were incubated with 0.12 mM
formaldehyde in the presence of 100 μM geniposide (C, H, M), 10 μM geniposide Rg1 (D, I, N), or TLJN containing 100 μM of geniposide and 10 μM
of ginsenoside Rg1 (B, G, L) at different time intervals (6, 12 and 24 h). Cells treated with formaldehyde alone (E, J, O) and no treatment (A, F, K) were
used as controls. Scale bars = 20 μM. Cell density assays of SH-SY5Y cells at different time intervals (6, 12, and 24 h) (P). Ctrl, control; FA, formaldehyde;
Gp, geniposide; Rg1, ginsenoside Rg1. Data are expressed as the mean ± SD from three independent experiments.
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removed after 12 h incubation with SH-SY5Y cells
and then geniposide-treated cells were incubated with
0.12 mM formaldehyde for another 12 h. As shown
by the CCK-8 assay (Figure 5A), cell viability of the
geniposide-pretreated group was significantly higher
(P < 0.01) than the formaldehyde alone treated group.
Geniposide (25 μM) increased the viability of cellsfrom 62.1% to 80.2%, similar to that of 100 and
250 μM geniposide.
On the other hand, we treated cells with 0.12 mM
formaldehyde for 6 h first, and then incubated cells with
geniposide or both geniposide and formaldehyde for
24 h. Results from the CCK-8 assay demonstrated
that geniposide could improve viability following
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Figure 4 Changes in formaldehyde levels in culture medium
and cell viability in the presence of geniposide. Decreases in
formaldehyde concentrations in the medium of cells treated with
geniposide (100 μM and 25 μM) for 24 h were detected by HPLC
when compared with the formaldehyde-only group (control; A).
Changes in SH-SY5Y cell viability in the presence of TLJN,
geniposide, or ginsenoside Rg1 at different concentrations (250 μM,
100 μM and 25 μM; B). Data are expressed as the mean ± SD from
at least three independent experiments. *P < 0.05, **P < 0.01 vs. the
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Figure 5 Geniposide protects SH-SY5Y cells from formaldehyde
injury. Conditions for the treatment of cells were as described in
Figure 2, except that SH-SY5Y cells were first incubated with
different concentrations of geniposide overnight, followed by
treatment with formaldehyde for 12 h. The viability of cells was
evaluated using the cell counting kit-8 (A). By contrast, cells were
first exposed to formaldehyde overnight (conditions referred to in
Figure 2), and then the medium was replaced with geniposide or
both geniposide and formaldehyde for 24 h, followed by
measurement of cell vitality (B). Gp, geniposide. Data are expressed
as the mean ± SD from three independent experiments. *P < 0.05,
vs. the group treated with formaldehyde alone.
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cells increased their viability from 37.9% to 54.2%
(P < 0.05). Viability increased from 15.6% to 36.1% in cells
pretreated with formaldehyde for 6 h and in cells exposed
to formaldehyde for 24 h following addition of geniposide
(P < 0.01). This demonstrates that protection of SH-SY5Y
cells by geniposide is not because of a direct interaction of
geniposide with formaldehyde, but because of the activa-
tion of related cellular pathways.
Geniposide suppresses apoptosis of SH-SY5Y cells in the
presence of formaldehyde
To determine how geniposide protects cells from
formaldehyde toxicity, we first monitored the rateof apoptosis after treatment. SH-SY5Y cells (plated
at 1×106) were grown in 60 mm plates overnight.
Culture medium was then replaced with serum-
free DMEM containing 0.12 mM formaldehyde
supplemented with 25 or 100 μM geniposide for
24 h. Flow cytometry revealed that 5.82% of non-
treated SH-SY5Y cells were apoptotic (Figure 6A).
Incubation with 100 μM geniposide (Figure 6B)
could suppress formaldehyde-induced apoptosis of
SH-SY5Y cells with the percentage of apoptotic
cells decreasing from 12.15% to 5.25% when
compared with formaldehyde-only treated cells










































Figure 6 Geniposide suppresses apoptosis of SH-SY5Y cells following formaldehyde treatment. SH-SY5Y cells (A) were treated with
0.12 mM formaldehyde in the presence (B) or absence of 100 μM geniposide (C) for 24 h, and then the rate of apoptosis was detected by flow
cytometry. Geniposide suppressed SH-SY5Y cell apoptosis following formaldehyde treatment as indicated. The percentages of apoptotic SH-SY5Y
cells (D) were analyzed. Data are expressed as the mean ± SD from three independent experiments. *P < 0.05, vs. the group incubated with
formaldehyde alone. The figures (A,B,C) are representative of three independent experiments.
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Bcl-2 is the founding member of the Bcl-2 family of
apoptosis regulator proteins [19-21]. Thus, we investigated
the changes in Bcl-2 mRNA and protein expression. Our
results showed that treatment of SH-SY5Y cells with
formaldehyde induced a robust decrease in both Bcl-2HCHO(mM)
Gp(µM)
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Figure 7 Geniposide regulates apoptotic-related genes expressions. G
protein levels of Bcl-2 (B) to antagonize formaldehyde-induced SH-SY5Y ce
geniposide for 24 h. The expression of Bcl-2, P53, caspase 3 and caspase 9 m
conditions were as described in Figure 2. Cells treated with formaldehyde
controls, respectively. Gp, geniposide. Data are expressed as the mean ± SD
with formaldehyde alone. The Gel electrophoresis is representative of threemRNA and protein levels, followed by an increase in
apoptotic cell death when cells were incubated with
formaldehyde. However, treatment with different
concentrations of geniposide (25 μM and 100 μM) was
able to rescue levels of both Bcl-2 mRNA (Figure 7A) and





















eniposide was able to regulate not only mRNA levels (A) but also
ll impairment. SH-SY5Y cells were incubated with formaldehyde and
RNA were measured by quantitative real time PCR (C). Treatment
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Figure 8 Effect of geniposide on the activities of SOD, GSHPx
and catalase in formaldehyde-injured SH-SY5Y cells. After
treatment of cells with different concentrations of geniposide
(25, 100 μM) and 0.12 mM formaldehyde for 24 h. SOD activity (A),
GSHPx activity (B) and catalase activity (C) were measured using
assay kits and a microplate reader. Cells treated with formaldehyde
alone and those with no treatment were used as positive and
negative controls, respectively. Gp, geniposide. The data are
represented as the mean ± SD from three independent experiments.
*P < 0.05 and **P < 0.01 vs. group treated with formaldehyde alone.
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exposure to formaldehyde, but treatment with geniposide
markedly increased the expression of Bcl-2 from 213.2%
(25 μM geniposide) to 259.3% (100 μM geniposide). We
also measured the expressions of P53, caspase 3 and
caspase 9 mRNA by quantitative real time PCR. P53 is a
key modulator of the cellular stress response, and activa-
tion of P53 can trigger apoptosis in many cell types
including neurons [22]. Caspases play essential roles in
apoptosis and caspase 3 is a key executer of apoptosis,
whose activation is mediated by the initiator caspases,
such as caspase 9 [23]. The expression of P53, caspase 3
and caspase 9 mRNA increased sharply by 261.5%, 248.2%
and 90.5%, respectively, in the formaldehyde-treated
group. In the geniposide-treated group, the expression of
these genes decreased markedly by 70.7% (P53), 82.3%
(caspase 3) and 75.8% (caspase 9) after 25 μM geniposide
treatment and by 70.0% (P53), 89.8% (caspase 3) and
80.1% (caspase 9) after 100 μM geniposide treatment.
These results suggest that Bcl-2, P53, caspase 3 and
caspase 9 are involved in the protective effect of geniposide
following formaldehyde injury of SH-SY5Y cells.
Geniposide increases the activity of SOD and GSHPx
The generation of excess levels of reactive oxygen
species (ROS) is important for the activation of apoptosis.
SOD, GSHPx and catalase play a critical antioxidative role
in tissues and organs [24]. Therefore, we next tested the
activity of SOD, GSHPx and catalase in cells. As shown in
Figure 8A and 8B, after exposure to formaldehyde, the
activity of SOD and GSHPx decreased significantly
(P < 0.05) when compared with the control. In contrast,
treatment with 100 μM geniposide markedly increased the
activity of SOD (from 63.7% to 107.2%, P < 0.01) and
GSHPx (from 81.5% to 127.5%, P < 0.01) when compared
with DMSO-incubated cells under our experimental
conditions. The activity of catalase (Figure 8C) did
not differ among the four experimental groups. This
result demonstrates that geniposide improves the activity
of SOD and GSHPx leading to suppression of apoptosis of
SH-SY5Y cells in the presence of formaldehyde.
Discussion
An increase in the concentration of endogenous
formaldehyde (in blood and urine) has been found to
correlate with an increase in age [7]. The concentration of
hippocampal formaldehyde in AD patients is significantly
higher than those of healthy seniors [7,25]. There is a
certain amount of formaldehyde existing in the body,
which is produced from several sources, such as the
reaction of malondialdehyde with protein [20] and the
methylation of DNA [5,26]. The cytotoxic mechanisms of
formaldehyde have been studied in several experimental
models. Formaldehyde is extremely reactive, cross-linkingwith proteins and with single stranded DNA, causing
cellular dysfunction and even apoptosis [27]. Excess
formaldehyde can also lead to endoplasmic reticulum
stress and oxidative stress [28], which has been termed
‘formaldehyde stress’ [5]. Formaldehyde can also induce
toxicity in neurons and astrocytes by multiple
means, and in astrocytes, decreasing glutamate trans-
porter expression, and inhibit glutamate uptake [29].










Figure 9 A putative mechanism for the protective effect of
geniposide on cells in the presence of formaldehyde.
Formaldehyde targets cell membranes and induces lipid
peroxidation, inducing mitochondrial dysfunction, oxidative stress,
and subsequent apoptosis. Reactive oxygen species (ROS),
including singlet oxygen, hydrogen peroxide, superoxide anion
and hydroxyl radicals, are important mediators of cellular injury,
and play an important role in oxidative stress. ROS-initiated
oxidative stress can be regulated by cell defense mechanisms,
such as superoxide dismutase (SOD), which are a class of
enzymes that catalyze the dismutation of superoxide and protect
the cell from superoxide toxicity. Bcl-2 is the founding member
of the Bcl-2 family of apoptosis regulator proteins, which tends
to make cells more resistant to oxidative stress and apoptosis.
P53 is a key modulator of the cellular stress response, and its
activation can trigger apoptosis in many cell types including
neurons. Caspase 3 is a key executer of apoptosis, whose
activation is mediated by caspase 9. As shown in our results,
geniposide is able to increase the activity of SOD and GSHPx
and modulate the expression of Bcl-2, P53, caspase 3 and caspase 9,
thus inducing a neuroprotective effect on SH-SY5Y cells.
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neurological disorders [30].
In our study, we found that TLJN could attenuate
formaldehyde-induced neurotoxicity in cultured SH-SY5Y
cells. Geniposide and ginsenoside Rg1 are the two main
ingredients of TLJN [14]. In a previous study, we have
shown that geniposide has a significant neuroprotective
effect by blocking the progressive cascade that leads to
cerebral ischemic injury and improving the expression of
neurotrophic factors [13]. Moreover, ginsenoside Rg1
significantly stimulates neurite outgrowth of PC12 cells in
the absence of nerve growth factor [31]. The present study
indicates that geniposide is also able to attenuate
formaldehyde-induced neurotoxicity, but that ginsenoside
Rg1 is ineffective under these conditions. TLJN was more
effective in neuroprotection than geniposide, exhibiting
some integrated effects of geniposide and ginsenoside
Rg1. Moreover, geniposide attenuated neurotoxicity in a
dose-dependent pattern. Treatment with 25 μmol/L
geniposide could increase cell viability from 39.3% to
57.6% (Figure 2B), with cell viability increasing markedly
with increasing dosage.
In addition to cell viability, the morphology and cell
number of SH-SY5Y cells following formaldehyde injury
was rescued in the presence of geniposide and TLJN.
While the protective effect of ginsenoside Rg1 on cellular
morphology and cell number could not be detected. Fur-
thermore, the concentration of formaldehyde in the cell
culture medium significantly decreased after treatment
with geniposide. Incubation with 25 μmol/L geniposide re-
duced the content of formaldehyde in the medium from
100% to 79.8%. This result indicates that there could be a
direct interaction between geniposide and formaldehyde.
However, this may also be because of the presence of
several formaldehyde metabolic enzymes, such as alcohol
dehydrogenase I, alcohol dehydrogenase III, formaldehyde
dehydrogenase and aldehyde dehydrogenase 2 [1,5].
Therefore, the reason for the reduction in formaldehyde
content may be because geniposide can upregulate the ac-
tivity of formaldehyde metabolic enzymes or increase the
metabolism of formaldehyde by healthy cells. We have
tested whether geniposide could protect SH-SY5Y cells
from formaldehyde injury following the addition of
geniposide and formaldehyde to the cell culture medium
in different orders. As shown in Figure 5, geniposide
added to cultures before, at the same time, or after cells
were exposed to formaldehyde resulted in an increase in
cell viability. These results indicate that both possibilities,
namely geniposide reacting with formaldehyde and
protecting cells directly, are plausible. However, dose-
dependent effects could not be observed under these ex-
perimental conditions. The lack of a dose-dependent effect
suggests that 25 μM geniposide may already cause a max-
imal effect.Geniposide, the active constituent of Gardenia
jasminoides, which is widely used in Chinese traditional
medicine, has been shown to have a neuroprotective
effect against neuronal apoptosis induced by Aβ,
CoCl2, and H2O2 [19,32,33]. Our study showed that
geniposide could also protect against neuronal apoptosis
induced by formaldehyde. Bcl-2 is an antiapoptotic
oncoprotein that can promote cell survival [24]. P53
is a key modulator of cellular stress responses, and its
activation triggers apoptosis in many cell types
including neurons [22]. Caspases play essential roles
in apoptosis and caspase 3 is a key executer of
apoptosis, whose activation is mediated by the initiator
caspases, such as caspase 9 [23]. Herein, geniposide
inhibited cell apoptosis through modulation of Bcl-2, P53,
caspase 3 and caspase 9 mRNA levels. Oxidative stress is
one of the major events that occur during neurological
diseases such as AD [1]. In addition, oxidative stress is
one of the main mechanisms for inducing apoptotic cell
death, in which levels of ROS are upregulated [19]. Cells
are susceptible to oxidative stress-induced apoptosis when
levels of intracellular antioxidants are downregulated.
SOD, GSHPx and catalase are important antioxidant
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radicals. In our study, the activity of SOD and GSHPx
in SH-SY5Y cells decreased significantly when exposed
to formaldehyde. However, treatment with 100 μmol/L
geniposide increased the activity of SOD from 63.7%
(formaldehyde alone) to 107.2% and that of GSHPx
from 81.5% to 127.5% (P < 0.01). Therefore, we propose
that geniposide inhibits apoptotic cell death following
formaldehyde injury by increasing the antioxidative and
antiapoptotic capacity of cells (Figure 9).
Conclusions
In the presence of TLJN, the viability of formaldehyde-
treated SH-SY5Y cells remarkably recovered. In addition,
the morphology of cells was rescued by TLJN and
geniposide, an effective ingredient of TLJN. The activity
of intracellular antioxidants (SOD and GSHPx), as
well as mRNA and protein levels of the antiapoptotic
gene Bcl-2 were upregulated after the addition of
geniposide. The expression of the apoptotic-related
gene - P53, apoptotic executer - caspase 3 and apoptotic
initiator - caspase 9 were downregulated after geniposide
treatment. Our results indicate that geniposide can
protect SH-SY5Y cells against formaldehyde stress by
modulating the expressions of Bcl-2, P53, caspase 3
and caspase 9, and increasing the activity of intracellular
SOD and GSHPx.
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